HITACHI TO HIGHLIGHT ITS NEW ARIETTA 850 PREMIUM ULTRASOUND SYSTEM AT RSNA 2017
Twinsburg Ohio, November 21, 2017 - Hitachi Healthcare will be exhibiting their latest premium ultrasound system, the ARIETTA 850, at this year’s Radiological Society of North America Annual General Meeting in Chicago, November 26 to December 1. The system, which received FDA 510(k) clearance this month, offers a collection of features designed to improve image quality, speed workflow, and extend the utility of ultrasound in radiology departments. ARIETTA 850 also supports the world’s first widely-available probe that uses capacitive micro-machined ultrasound transducers (CMUT) rather than piezoelectric crystals to transmit and receive the ultrasound signal.
The new system builds upon the advanced capabilities of Hitachi’s ARIETTA family of ultrasound scanners, adding features like eFocusing, which removes the need for focal zone adjustments by dynamically focusing from the near to far-field of the image. It also expands interventional capabilities through a collection of features that work in conjunction with Hitachi’s Real-time Virtual Sonography fusion software to automatically perform fusion registration, compensate for needle flexion during biopsy procedures, and deliver real-time visual maps of estimated RF ablation zones.
Hitachi will be holding live presentations introducing the ARIETTA 850 and its groundbreaking new CMUT probe throughout the week at Booth 2511 South Hall. For each attendee Hitachi will be making a donation to the Red Cross Disaster Relief Fund in support of the victims of Hurricanes Irma, Jose and Maria. You can book your demo at www.hitachihealthcare.com/RSNA2017 or plan to stop by and see one of the scheduled demonstrations.
Hitachi Healthcare Americas, located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Ltd, offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT, Ultrasound and IT technologies provide speed, comfort and quality for both physicians and patients alike and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Visit www.hitachihealthcare.com/RSNA2017
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges. The company’s consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information on Hitachi, please visit the company’s website at www.hitachi.com.
Hitachi Healthcare Americas
+1 330 425-1131 x3385